22 August 2018
Visiongain’s new report Global Pre-Filled Syringes Market Forecast 2017-2027: Glass Pre-Filled Syringes, Plastic Pre-Filled Syringes, Pen Injectors and Autoinjectors indicates that the global pre-filled syringes market will see $7,629m in spending in 2021.
The lead analyst of the report said: “Visiongain estimates that the world pre-filled syringes market reached $4,663m in revenue in 2016. The leading national markets in 2016 were the US, Japan and Germany, which accounted for 54.9% of revenues. Glass pre-filled syringes dominated the market in 2016, accounting for 64.0% of revenues. That submarket experienced strong growth in the last decade, driven by uptake in many therapeutic and regional markets.
Plastic syringes offer benefits over traditional glass syringes, although they cost more to manufacture. In 2016, pen injectors and autoinjectors constituted the second largest sector of the pre-filled syringe market, with estimated sales revenues totalling $1,303m, Applications for these products are growing, with many established biologics for chronic diseases now marketed in combination with these devices.”
The 212-page report contains 68 tables and 55 figures that add visual analysis in order to explain developing trends within the Global Pre-Filled Syringes market. Visiongain provides revenue forecasts for the period 2017-2027 as well as qualitative analyses for the leading segments of this market: Glass Pre-Filled Syringes, Plastic Pre-Filled Syringes, Pen Injectors and Autoinjectors
This report provides 10-year forecasts for the leading therapeutic sectors for the Pre-Filled Syringes market. Moreover, this report provides 10-year forecasts for the leading pre-filled devices.
The 212-page report offers market forecasts and analysis for 11 leading national markets: the US, Japan, EU5 (the UK, Germany, France, Spain, and Italy) and BRIC (Brazil, Russia, China, and India). In addition, the report contains a dedicated leading companies’ chapter covering leading pre-filled syringes manufacturers and related technology manufacturers
The Global Pre-Filled Syringes Market Forecast 2017-2027: Glass Pre-Filled Syringes, Plastic Pre-Filled Syringes, Pen Injectors and Autoinjectors report will be of value to anyone who wants to better understand the pre-filled syringes market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the pre-filled syringes industry.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business conferences, newsletters, management reports and e-zines focusing on the automotive, chemical, cyber, defence, energy, pharmaceutical, materials and telecoms sectors.
Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.
21 July 2021
Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.
20 July 2021
Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.
14 July 2021
Digital innovation in clinical trials and renewed focus on home production will ensure a high growth market for supply chain optimisation.